These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
575 related articles for article (PubMed ID: 30126828)
1. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors. El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828 [TBL] [Abstract][Full Text] [Related]
2. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas. Chen SC; Shyr YM; Wang SE HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708 [TBL] [Abstract][Full Text] [Related]
3. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome? Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717 [TBL] [Abstract][Full Text] [Related]
4. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas. Wang SE; Shyr YM; Su CH; Chen TH; Wu CW Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381 [TBL] [Abstract][Full Text] [Related]
5. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322 [TBL] [Abstract][Full Text] [Related]
6. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy. Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183 [TBL] [Abstract][Full Text] [Related]
7. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417 [TBL] [Abstract][Full Text] [Related]
8. Periampullary adenocarcinoma: analysis of 5-year survivors. Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545 [TBL] [Abstract][Full Text] [Related]
9. Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study. Hafeez Bhatti AB; Dar FS; Sahaab E; Khan NY; Zia H; Rana A; Salih M; Shah NH Int J Surg; 2016 Jul; 31():58-62. PubMed ID: 27262530 [TBL] [Abstract][Full Text] [Related]
11. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP BMC Cancer; 2008 Jan; 8():5. PubMed ID: 18194510 [TBL] [Abstract][Full Text] [Related]
12. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation. Tsao JI; Rossi RL; Lowell JA Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796 [TBL] [Abstract][Full Text] [Related]
13. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer]. Roder JD; Siewert JR Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655 [TBL] [Abstract][Full Text] [Related]
14. The histopathologic type of the periampullary tumors. Is it important for survival? Georgescu SO; Neacşu CN; Vintilă D; Popa P; Florea N; Mihailovici MS Chirurgia (Bucur); 2009; 104(6):697-700. PubMed ID: 20187467 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience). El Nakeeb A; El Shobary M; El Dosoky M; Nabeh A; El Sorogy M; El Eneen AA; abu Zeid M; Elwahab MA Hepatogastroenterology; 2014; 61(133):1426-38. PubMed ID: 25436321 [TBL] [Abstract][Full Text] [Related]
16. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors]. Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331 [TBL] [Abstract][Full Text] [Related]
17. Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Riall TS; Cameron JL; Lillemoe KD; Winter JM; Campbell KA; Hruban RH; Chang D; Yeo CJ Surgery; 2006 Nov; 140(5):764-72. PubMed ID: 17084719 [TBL] [Abstract][Full Text] [Related]
18. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas. Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192 [TBL] [Abstract][Full Text] [Related]
20. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]